Nese GOCER GUROK, Ibrahim KOKCAM, Demet CİCEK, Süleyman AYDIN, Denizmen AYGUN

Serum preptin and amylin levels in acne vulgaris patients

Acne vulgaris is a common disease with multi-factorial etiology that occupies the pilosebaceous unit. Several recent studies demonstrated that insulin and insulin resistance can play a role in acne pathogenesis. In the present study, the roles of preptin and amylin, which are directly associated with insulin secretion and released from pancreas beta cells, in acne vulgaris pathogenesis were investigated. The study was conducted with 40 cases with acne vulgaris and the control group that included 40 healthy subjects with similar body mass index. Serum preptin and amylin levels and fasting blood glucose, triglyceride, total cholesterol, LDL, VLDL, HDL, C-peptide, insulin and HbA1c levels were examined in the study group. HOMA-IR values were calculated. Although patient group serum preptin and amylin levels were higher when compared to the control group, however the difference was not statistically significant (p> 0.05). It was determined that there was a positive correlation between severity of the disease and amylin levels. In the patient group, it was found that the glucose level was significantly higher when compared to the control group (p 0.05). It is considered that increased preptin and amylin levels in acne vulgaris patients may be associated with the etiopathogenesis of the disease. We also considered that decreasing the elevated levels of these two peptides to normal levels may be helpful for the treatment of the disease.

PDF

___

Zaenglein AI, Graber EM, Thiboutot DM, et al. Acne vulgaris and acneiform eruptions. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ editors. Fitzpatrick’s Dermatology in General Medicine. 7th ed, New York: McGraw-Hill, 2008:690-703.

Elston DM, James WD, Berger TG editors. Akne vulgaris. andrews’ diseases of the skin clinical dermatology. 10th edt, Philadelphia: W.B. Saunders Company, 2008:231-51.

Chen WC, Zouboulis CC. Hormones and the pilosebaceous unit. Dermatoendocrinol. 2009;1:81-6.

Rosenfield RL. Polycystic ovary syndrome and insulin resistant hyperinsulinemia. J Am Acad Dermatol. 2001;45:95-104.

Bowe WP, Joshi SS, Shalita AR. Diet and acne. J Am Acad Dermatol. 2009;63:124-41.

Keri JE, Nijhawan RI. Diet and Acne. Exp Rev Dermatol. 2008;3:437-40.

Cordain L. Implications for the role of diet in acne. Semin Cutan Med Surg. 2005;24:84-91.

Sattar N, Hopkinson ZE, Greer IA. Insulin-sensitising agents in polycystic ovary syndrome. Lancet. 1998;351:305-7.

Essah PA, Wickham EP, Nunley JR, et al. Dermatology of androgen-related disorders. Clin dermatol. 2006;24:289-98.

Kolodziejczyk B, Duleba AJ, Spaczynski RZ, et al. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril. 2000;73:1149-54.

Liu YS, Lu Y, Liu W, et al. Connective tissue growth factor is a downstream mediator for preptin-induced proliferation and differentiation in human osteoblasts. Amino Acids. 2010;38:763-9.

Buchanan CM, Phillips AR, Cooper GJ. Preptin derived from proinsulinlike growth factor II (proIGF-II) is secreted from pancreatic islet b-cells and enhances insulin secretion. Biochem J. 2001;360:431-9.

Zhang XX, Pan YH, Huang YM, et al. Neuroendocrine hormone amylin in diabetes. World J Diabetes. 2016;7:189-97.

Lutz TA. The role of amilin in the control of energy homeostasis. Am J Physiol Regul Integr Comp Physiol. 2010;298:1475-84.

Dogan FB, Cicek D, Aydin S, et al. Serum preptin and amylin values in psoriasis vulgaris and behçet’s patients. J Clin Lab Anal. 2016;30:165-8.

Ahmad E, Ahmad A, Singh S, et al. A mechanistic approach for islet amyloid polypeptide aggregation to develop anti-amyloidogenic agents for type-2 diabetes. Biochimie. 2011;93:793-805.

Reinehr T, de Sousa G, Niklowitz P, et al. Amilin and its relation to insulin and lipids in obese children before and after weight loss. Obesity. 2007;15:200611.

Sterry W, Strober BE, Menter A. Obesity In Psoriasis: The metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol. 2007;157:649-55.

Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997;36:416-8.

Kondo N, Nomura M, Nakaya Y, et al. Association of inflammatory marker and highly sensitive C Reactive Protein with aerobic exercise capacity, maximum oxygen uptake and insulin resistance in healthy middle aged volunteers. Circ J. 2005;69:452-7.

Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20 years and older J Am Acad Dermatol. 2008;58:56-9.

Zouboulis CC. Acne vulgaris. The role of hormones. Hautarzt. 2010;61:107-14.

Del Prete M, Mauriello MC, Faggiano A, et al. Insulin resistance and acne: a new risk factor for men? Endocrine. 2012;42:555-60.

Melnik BC. Acne and diet. Hautarzt. 2013;64:252-62.

Di Landro A, Cazzaniga S, Parazzini F, et. al. Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol. 2012;67:1129-35.

Nagpal M, De D, Handa S, et al. Insulin Resistance and Metabolic Syndrome in Young Men With Acne. JAMA Dermatol. 2016;152:399-404.

Celik O, Celik N, Hascalik S, et al. An appraisal of serum preptin levels in PCOS. Fertil Steril. 2010;95:314-6.

Bu Z, Kuok K, Meng J, et al. The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level. Reprod Biol Endocrinol. 2012;10:10.

Yang G, Li L, Chen W, et al. Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Ann Med. 2009;41:52-6.

Güzel S, Güneş N. Amilin ve glukoz homeostazisi üzerine etkileri. Uludag Univ J Fac Vet Med. 2011;30:65-72.

James S, Moralez J, Nagamani M. Increased secretion of amylin in women with polycystic ovary syndrome. Fertil Steril. 2010;94:211-5.

Çerman AA, Aktaş E, Altunay İK, et al. Dietary glycemic factors, insülin resistance and adiponectin levels in acne vulgaris. J Am Acad Dermetol. 2016;75:155-62.

Karadağ AS, Ertuğrul DT, Takci Z, et al. The effect of isotretinoin on retinolbinding protein 4, leptin, adiponectin and insulin resistance in acne vulgaris patients. Dermatology. 2015;230:70-4.